Entrada Therapeutics Reports Third Quarter 2023 Financial Results
Go back to Entrada Therapeutics Reports Third Quarter 2023 Financial Results| (NASDAQ: TRDA) | Delayed: 7.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.60 | 52 Week High | $ | |||
| Open | $7.60 | 52 Week Low | $ | |||
| Day High | $7.60 | P/E | N/A | |||
| Day Low | $7.60 | EPS | $ | |||
| Volume | 239 | |||||

